PCM
TEVA icon

Penserra Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Penserra Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$1K – 1367
2024
Q1 		$1K Buy
+300
New +$3.78K ﹤0.01% 1220

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Penserra Capital Management's TEVA Position: Q1 2026 in Review

Penserra Capital Management opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 3,444 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in TEVA as recently as Q1 2025.

Penserra Capital Management first reported a position in TEVA in Q3 2017 and has held it in 11 quarters since. The position peaked at $2.62M in Q2 2024. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Penserra Capital Management held 3,444 shares of Teva Pharmaceuticals worth $103K as of Q1 2026.
  • Teva Pharmaceuticals was a new Penserra Capital Management position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #730 holding.
  • Penserra Capital Management first reported a position in Teva Pharmaceuticals in Q3 2017 and has held it in 11 quarters since.
  • Penserra Capital Management's Teva Pharmaceuticals position peaked at $2.62M in Q2 2024.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.